Lab
Wellnow Urgent Care, PC
Wellnow Urgent Care, PC was paid $106.41M by Medicaid between Jan 2018 and Dec 2024, across 66 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 33% of everything it billed.
33Billing provider infoWELLNOW URGENT CARE, PC
LIVERPOOL, NY 13090
LIVERPOOL, NY 13090
33aNPI1669825162assigned 07/20/2016
33bProvider typeClinical Medical Laboratory
28Total paid$106.41M
24GClaims2,180,426
24DCodes billed66
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in New York
Rank by total paid#4 of 116
Median peer was paid$618K
This provider vs. median172×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 29,322 | $1.82M | |
| 2019 | 115,815 | $7.07M | |
| 2020 | 220,355 | $11.06M | |
| 2021 | 527,856 | $22.34M | |
| 2022 | 476,569 | $21.98M | |
| 2023 | 454,765 | $22.24M | |
| 2024incomplete | 355,744 | $19.90M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 33% | 538,409 | 528,409 | $34.95M |
| S9083 | Global fee urgent care centers | 18% | 171,131 | 168,534 | $19.23M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 17% | 187,396 | 182,942 | $17.92M |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 11% | 145,209 | 144,725 | $11.66M |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 4.9% | 38,635 | 38,224 | $5.17M |
| 99050 | 3.7% | 345,078 | 342,416 | $3.90M | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 2.7% | 126,405 | 119,926 | $2.82M |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1.4% | 23,149 | 21,953 | $1.51M |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 1.3% | 54,184 | 52,862 | $1.33M |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.0% | 22,867 | 22,483 | $1.07M |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 17,313 | 17,291 | $1.02M |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 91,497 | 47,231 | $982K |
54 more codes
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 5,054 | $893K |
| 99051 | <1% | 124,737 | $884K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 36,714 | $780K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 115,754 | $533K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 23,130 | $502K |
| 99205 | Prolong outpt/office vis | <1% | 1,735 | $344K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 5,720 | $216K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 6,566 | $118K |
| 81025 | <1% | 19,564 | $68K | |
| 81003 | <1% | 49,562 | $60K | |
| 73610 | <1% | 1,945 | $46K | |
| 73630 | <1% | 2,036 | $45K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 3,416 | $31K |
| S9088 | Services provided in an urgent care center (list in addition to code for service) | <1% | 1,035 | $30K |
| 12001 | <1% | 519 | $29K | |
| 87807 | <1% | 2,972 | $28K | |
| 73130 | <1% | 1,125 | $26K | |
| 73110 | <1% | 904 | $25K | |
| 29540 | <1% | 1,257 | $24K | |
| E0114 | Crutches underarm, other than wood, adjustable or fixed, pair, with pads, tips and handgrips | <1% | 609 | $22K |
| 90715 | <1% | 771 | $22K | |
| 93000 | <1% | 1,712 | $17K | |
| 73140 | <1% | 588 | $14K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 886 | $10K |
| 73562 | <1% | 383 | $10K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,063 | $9K |
| 73030 | <1% | 361 | $8K | |
| L3580 | Orthopedic shoe addition, convert instep to velcro closure | <1% | 129 | $6K |
| 86308 | <1% | 1,528 | $6K | |
| 10060 | <1% | 82 | $4K | |
| 29530 | <1% | 195 | $4K | |
| L3807 | Wrist hand finger orthosis, without joint(s), prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise | <1% | 24 | $4K |
| 71101 | <1% | 145 | $4K | |
| 73080 | <1% | 100 | $2K | |
| 82962 | <1% | 630 | $1K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,401 | $952.20 |
| 29125 | <1% | 29 | $909.61 | |
| 29260 | <1% | 30 | $620.25 | |
| 69209 | <1% | 84 | $589.93 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 785 | $573.24 |
| 0002A | <1% | 18 | $536.40 | |
| 72100 | <1% | 25 | $488.54 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 757 | $422.42 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 660 | $411.83 |
| 0001A | <1% | 13 | $405.69 | |
| S8451 | Splint, prefabricated, wrist or ankle | <1% | 66 | $311.69 |
| 71045 | Radiologic examination, chest; single view | <1% | 32 | $298.20 |
| 73560 | <1% | 12 | $167.15 | |
| S0119 | Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) | <1% | 235 | $149.28 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 462 | $57.86 |
| Q4049 | Finger splint, static | <1% | 13 | $11.05 |
| A6448 | Light compression bandage, elastic, knitted/woven, width less than three inches, per yard | <1% | 459 | $1.16 |
| A4565 | Slings | 0% | 13 | $0.00 |
| A6449 | Light compression bandage, elastic, knitted/woven, width greater than or equal to three inches and less than five inches, per yard | 0% | 108 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBIERNBAUM, ROBERT (OWNER)
| Provider | Location | Paid |
|---|---|---|
| Pic Indiana PC | Mishawaka, IN | $10.70M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.